SUN PHARMA ADV.RES.CO.LTD (SPARC) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products.[1]

SPARCUpdated 25 Jul 2026, 14:18

Sun Pharma Adv.res.co.ltd

Market Cap

₹7,017Cr.

Current Price

₹216

High / Low

₹289/108

Stock P/E

4.49

Book Value₹41.1
Dividend Yield0.00%
ROCE165%
ROE281%
Face Value₹1.00

About

Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days47217882207625745075822
Inventory Days00000000
Days Payable
Cash Conversion Cycle47217882207625745075822
Working Capital Days20-161-60-232-98-842-268-301-193-746-1,778214
ROCE %-32%-71%-94%-143%-62%-183%-242%-218%-67%-109%-298%165%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 25 July 2026 at 14:18


Designed & Shipped by Harshit Bansal